Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Herpes Genitalis
- A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Vaccine Against HSV-2 in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent HSV-2 Genital Herpes
- Study of 2LHERP® in Genital Herpes Infections
- Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
- Melatonin Effects on Genital Herpes in Brazilian Women
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food
- Evaluating New Formulation of Therapeutic HSV-2 Vaccine
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
- Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women
- A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes
- Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
- Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
- Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
- GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women
- Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
- A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
- Effect of HSV-2 Suppressive Therapy on Sexual Behavior
- HSV-2 Shedding Resolution After Acyclovir Treatment
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
- Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
- Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
- Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
- Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
- Trial Evaluating Safety, Tolerability and Immune Response of AG-707
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
- Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission
- Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes
- A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
- Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
- A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding
- A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
- A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients